CN Stock MarketDetailed Quotes

600062 China Resources Double-Crane Pharmaceutical

Watchlist
  • 20.55
  • -0.46-2.19%
Market Closed Dec 13 15:00 CST
21.36BMarket Cap15.84P/E (TTM)

China Resources Double-Crane Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
1.18%8.55B
1.46%5.93B
2.26%2.84B
6.20%10.22B
18.02%8.45B
18.99%5.84B
10.11%2.77B
5.64%9.63B
4.11%7.16B
6.07%4.91B
Operating revenue
1.18%8.55B
1.46%5.93B
2.26%2.84B
6.20%10.22B
18.02%8.45B
18.99%5.84B
10.11%2.77B
5.64%9.63B
4.11%7.16B
6.07%4.91B
Other operating revenue
----
-40.28%44.6M
----
5.23%108.38M
----
23.35%74.69M
----
32.24%102.99M
----
80.22%60.55M
Total operating cost
3.15%7.15B
2.82%4.9B
1.37%2.35B
5.12%8.71B
16.05%6.93B
18.32%4.77B
10.22%2.31B
3.14%8.28B
2.14%5.97B
2.41%4.03B
Operating cost
-1.98%3.55B
-0.19%2.46B
-0.27%1.23B
6.71%4.58B
13.50%3.62B
15.58%2.47B
12.48%1.23B
6.41%4.29B
9.95%3.19B
10.05%2.13B
Operating tax surcharges
2.73%109.61M
3.06%75.33M
8.45%34.23M
10.01%132.8M
26.53%106.69M
22.51%73.1M
2.69%31.56M
4.29%120.72M
-4.18%84.32M
-2.22%59.66M
Operating expense
8.12%2.29B
1.94%1.56B
3.30%741.56M
-1.80%2.68B
13.04%2.12B
16.76%1.54B
0.03%717.88M
-2.61%2.73B
-8.27%1.88B
-7.83%1.31B
Administration expense
5.27%748.52M
8.33%494.95M
-0.76%226.4M
5.64%794.51M
25.57%711.06M
27.25%456.91M
25.39%228.13M
6.84%752.09M
-0.33%566.26M
5.19%359.06M
Financial expense
41.76%-25.23M
15.70%-24.41M
-169.69%-13.67M
54.23%-43.84M
31.21%-43.32M
9.51%-28.96M
38.07%-5.07M
-159.49%-95.79M
-168.43%-62.97M
-122.41%-32.01M
-Interest expense (Financial expense)
-18.98%9.68M
-22.26%6.55M
-9.62%3.16M
32.42%14.07M
222.61%11.95M
86.12%8.43M
67.29%3.49M
-8.60%10.62M
-57.38%3.7M
-19.22%4.53M
-Interest Income (Financial expense)
24.20%-35.64M
5.01%-27.57M
-37.92%-15.89M
40.98%-52.93M
11.60%-47.02M
-8.10%-29.02M
5.33%-11.52M
-64.76%-89.68M
-48.23%-53.18M
-15.06%-26.85M
Research and development
14.33%472.69M
24.34%328.65M
17.06%130.33M
16.37%561.46M
30.34%413.44M
36.61%264.32M
33.29%111.34M
17.80%482.48M
19.07%317.2M
7.24%193.49M
Credit Impairment Loss
125.13%4.99M
100.96%239.48K
-39.04%-23.62M
27.11%-1.73M
17.77%-19.84M
9.15%-25.02M
-3.76%-16.99M
-84.19%-2.37M
-52.53%-24.12M
-53.49%-27.54M
Asset Impairment Loss
-16.38%-20.71M
1,559.06%10M
709.40%3.46M
-440.55%-101.7M
-302.12%-17.8M
74.43%-685.62K
127.33%427.85K
71.16%-18.81M
-52.65%-4.43M
-0.37%-2.68M
Other net revenue
85.73%189.21M
106.41%141.55M
25.16%4.13M
-102.14%-1.78M
84.21%101.87M
91.42%68.58M
-31.00%3.3M
51.14%83.28M
-16.25%55.3M
8.82%35.83M
Fair value change income
----
----
----
130.45%13.8M
2,416.81%11.01M
2,148.38%6.98M
-51.83%2.85M
-83.06%5.99M
-98.41%437.52K
-101.57%-340.63K
Invest income
73.37%126.91M
70.01%79.94M
227.68%12.77M
-22.69%12.55M
175.54%73.2M
132.69%47.02M
4,348.54%3.9M
-40.14%16.23M
111.90%26.57M
697.13%20.21M
-Including: Investment income associates
73.37%126.91M
----
227.68%12.77M
-22.69%12.55M
175.54%73.2M
----
4,348.54%3.9M
3.82%16.23M
111.90%26.57M
697.13%20.21M
Asset deal income
-12.62%480.9K
128.06%2.04M
-52.71%319.75K
97.53%-56.13K
122.09%550.36K
-57.32%895.9K
169.81%676.15K
-320.00%-2.27M
-155.60%-2.49M
45.87%2.1M
Other revenue
41.65%77.54M
25.21%49.32M
-9.96%11.2M
-10.85%75.35M
-7.75%54.74M
-10.65%39.39M
-29.67%12.44M
45.43%84.52M
47.77%59.34M
57.91%44.08M
Operating profit
-1.92%1.59B
2.12%1.17B
6.87%494.44M
6.16%1.52B
30.48%1.62B
24.76%1.15B
9.11%462.64M
25.52%1.43B
13.43%1.24B
25.88%918.72M
Add:Non operating Income
28.92%37.29M
19.64%33.28M
980.80%18.77M
133.88%71.06M
46.00%28.92M
81.64%27.82M
234.57%1.74M
617.61%30.38M
214.03%19.81M
272.82%15.31M
Less:Non operating expense
5.55%6.91M
-14.71%5.83M
87.42%2.8M
-13.09%19.57M
-59.68%6.55M
-37.71%6.84M
-70.45%1.49M
12.62%22.52M
194.44%16.24M
202.14%10.98M
Total profit
-1.40%1.62B
2.63%1.2B
10.27%510.42M
9.17%1.57B
31.90%1.64B
26.45%1.17B
10.35%462.88M
27.98%1.43B
13.68%1.24B
26.39%923.06M
Less:Income tax cost
-19.90%205.58M
-15.02%144.4M
32.87%105.71M
19.55%240.61M
15.69%256.67M
9.40%169.93M
7.32%79.56M
35.03%201.27M
30.66%221.86M
44.17%155.33M
Add:Adjusted items effecting net profit
----
----
----
----
--0.01
----
----
----
----
----
Net profit
2.03%1.41B
5.64%1.05B
5.58%404.71M
7.48%1.33B
35.42%1.38B
29.90%997.27M
11.00%383.33M
26.90%1.23B
10.56%1.02B
23.31%767.73M
Net profit from continuing operation
2.03%1.41B
5.64%1.05B
5.58%404.71M
7.48%1.33B
35.42%1.38B
29.90%997.27M
11.00%383.33M
26.90%1.23B
10.56%1.02B
23.31%767.73M
Less:Minority Profit
900.82%14.7M
-44.33%7M
-234.83%-11.4M
-113.29%-7.12M
-96.59%1.47M
-59.54%12.58M
-36.85%8.45M
47.04%53.59M
22.50%43.09M
11.03%31.09M
Net profit of parent company owners
1.07%1.4B
6.28%1.05B
11.00%416.11M
12.96%1.33B
41.24%1.38B
33.67%984.69M
12.92%374.88M
26.12%1.18B
10.08%978.68M
23.89%736.64M
Earning per share
Basic earning per share
0.83%1.3596
6.35%1.0199
11.01%0.4075
14.09%1.3002
41.43%1.3484
33.96%0.959
15.37%0.3671
27.06%1.1396
11.88%0.9534
25.60%0.7159
Diluted earning per share
0.83%1.3596
6.35%1.0199
10.93%0.405
14.09%1.3002
42.55%1.3484
33.96%0.959
14.74%0.3651
27.06%1.1396
11.00%0.9459
25.60%0.7159
Other composite income
-103.06%-2.8K
-100.85%-781.09
-101.53%-1.32K
-41.41%858.64K
719.17%91.3K
1,698.87%92.05K
16,679.61%86.31K
120.94%1.47M
886.13%11.15K
380.46%5.12K
Other composite income of parent company owners
-103.06%-2.8K
-100.85%-781.09
-101.53%-1.32K
-53.18%858.44K
719.17%91.3K
1,698.87%92.05K
16,679.61%86.31K
128.00%1.83M
886.13%11.15K
380.46%5.12K
Other composite income of minority owners
----
----
----
100.06%205.24
----
----
----
18.19%-367.98K
----
----
Total composite income
2.02%1.41B
5.63%1.05B
5.55%404.71M
7.42%1.33B
35.43%1.38B
29.91%997.36M
11.02%383.42M
27.97%1.24B
10.56%1.02B
23.31%767.73M
Total composite income of parent company owners
1.07%1.4B
6.27%1.05B
10.97%416.11M
12.86%1.33B
41.24%1.38B
33.69%984.78M
12.95%374.96M
27.20%1.18B
10.08%978.69M
23.89%736.64M
Total composite income of minority owners
900.82%14.7M
-44.33%7M
-234.83%-11.4M
-113.38%-7.12M
-96.59%1.47M
-59.54%12.58M
-36.85%8.45M
47.85%53.22M
22.50%43.09M
11.03%31.09M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 1.18%8.55B1.46%5.93B2.26%2.84B6.20%10.22B18.02%8.45B18.99%5.84B10.11%2.77B5.64%9.63B4.11%7.16B6.07%4.91B
Operating revenue 1.18%8.55B1.46%5.93B2.26%2.84B6.20%10.22B18.02%8.45B18.99%5.84B10.11%2.77B5.64%9.63B4.11%7.16B6.07%4.91B
Other operating revenue -----40.28%44.6M----5.23%108.38M----23.35%74.69M----32.24%102.99M----80.22%60.55M
Total operating cost 3.15%7.15B2.82%4.9B1.37%2.35B5.12%8.71B16.05%6.93B18.32%4.77B10.22%2.31B3.14%8.28B2.14%5.97B2.41%4.03B
Operating cost -1.98%3.55B-0.19%2.46B-0.27%1.23B6.71%4.58B13.50%3.62B15.58%2.47B12.48%1.23B6.41%4.29B9.95%3.19B10.05%2.13B
Operating tax surcharges 2.73%109.61M3.06%75.33M8.45%34.23M10.01%132.8M26.53%106.69M22.51%73.1M2.69%31.56M4.29%120.72M-4.18%84.32M-2.22%59.66M
Operating expense 8.12%2.29B1.94%1.56B3.30%741.56M-1.80%2.68B13.04%2.12B16.76%1.54B0.03%717.88M-2.61%2.73B-8.27%1.88B-7.83%1.31B
Administration expense 5.27%748.52M8.33%494.95M-0.76%226.4M5.64%794.51M25.57%711.06M27.25%456.91M25.39%228.13M6.84%752.09M-0.33%566.26M5.19%359.06M
Financial expense 41.76%-25.23M15.70%-24.41M-169.69%-13.67M54.23%-43.84M31.21%-43.32M9.51%-28.96M38.07%-5.07M-159.49%-95.79M-168.43%-62.97M-122.41%-32.01M
-Interest expense (Financial expense) -18.98%9.68M-22.26%6.55M-9.62%3.16M32.42%14.07M222.61%11.95M86.12%8.43M67.29%3.49M-8.60%10.62M-57.38%3.7M-19.22%4.53M
-Interest Income (Financial expense) 24.20%-35.64M5.01%-27.57M-37.92%-15.89M40.98%-52.93M11.60%-47.02M-8.10%-29.02M5.33%-11.52M-64.76%-89.68M-48.23%-53.18M-15.06%-26.85M
Research and development 14.33%472.69M24.34%328.65M17.06%130.33M16.37%561.46M30.34%413.44M36.61%264.32M33.29%111.34M17.80%482.48M19.07%317.2M7.24%193.49M
Credit Impairment Loss 125.13%4.99M100.96%239.48K-39.04%-23.62M27.11%-1.73M17.77%-19.84M9.15%-25.02M-3.76%-16.99M-84.19%-2.37M-52.53%-24.12M-53.49%-27.54M
Asset Impairment Loss -16.38%-20.71M1,559.06%10M709.40%3.46M-440.55%-101.7M-302.12%-17.8M74.43%-685.62K127.33%427.85K71.16%-18.81M-52.65%-4.43M-0.37%-2.68M
Other net revenue 85.73%189.21M106.41%141.55M25.16%4.13M-102.14%-1.78M84.21%101.87M91.42%68.58M-31.00%3.3M51.14%83.28M-16.25%55.3M8.82%35.83M
Fair value change income ------------130.45%13.8M2,416.81%11.01M2,148.38%6.98M-51.83%2.85M-83.06%5.99M-98.41%437.52K-101.57%-340.63K
Invest income 73.37%126.91M70.01%79.94M227.68%12.77M-22.69%12.55M175.54%73.2M132.69%47.02M4,348.54%3.9M-40.14%16.23M111.90%26.57M697.13%20.21M
-Including: Investment income associates 73.37%126.91M----227.68%12.77M-22.69%12.55M175.54%73.2M----4,348.54%3.9M3.82%16.23M111.90%26.57M697.13%20.21M
Asset deal income -12.62%480.9K128.06%2.04M-52.71%319.75K97.53%-56.13K122.09%550.36K-57.32%895.9K169.81%676.15K-320.00%-2.27M-155.60%-2.49M45.87%2.1M
Other revenue 41.65%77.54M25.21%49.32M-9.96%11.2M-10.85%75.35M-7.75%54.74M-10.65%39.39M-29.67%12.44M45.43%84.52M47.77%59.34M57.91%44.08M
Operating profit -1.92%1.59B2.12%1.17B6.87%494.44M6.16%1.52B30.48%1.62B24.76%1.15B9.11%462.64M25.52%1.43B13.43%1.24B25.88%918.72M
Add:Non operating Income 28.92%37.29M19.64%33.28M980.80%18.77M133.88%71.06M46.00%28.92M81.64%27.82M234.57%1.74M617.61%30.38M214.03%19.81M272.82%15.31M
Less:Non operating expense 5.55%6.91M-14.71%5.83M87.42%2.8M-13.09%19.57M-59.68%6.55M-37.71%6.84M-70.45%1.49M12.62%22.52M194.44%16.24M202.14%10.98M
Total profit -1.40%1.62B2.63%1.2B10.27%510.42M9.17%1.57B31.90%1.64B26.45%1.17B10.35%462.88M27.98%1.43B13.68%1.24B26.39%923.06M
Less:Income tax cost -19.90%205.58M-15.02%144.4M32.87%105.71M19.55%240.61M15.69%256.67M9.40%169.93M7.32%79.56M35.03%201.27M30.66%221.86M44.17%155.33M
Add:Adjusted items effecting net profit ------------------0.01--------------------
Net profit 2.03%1.41B5.64%1.05B5.58%404.71M7.48%1.33B35.42%1.38B29.90%997.27M11.00%383.33M26.90%1.23B10.56%1.02B23.31%767.73M
Net profit from continuing operation 2.03%1.41B5.64%1.05B5.58%404.71M7.48%1.33B35.42%1.38B29.90%997.27M11.00%383.33M26.90%1.23B10.56%1.02B23.31%767.73M
Less:Minority Profit 900.82%14.7M-44.33%7M-234.83%-11.4M-113.29%-7.12M-96.59%1.47M-59.54%12.58M-36.85%8.45M47.04%53.59M22.50%43.09M11.03%31.09M
Net profit of parent company owners 1.07%1.4B6.28%1.05B11.00%416.11M12.96%1.33B41.24%1.38B33.67%984.69M12.92%374.88M26.12%1.18B10.08%978.68M23.89%736.64M
Earning per share
Basic earning per share 0.83%1.35966.35%1.019911.01%0.407514.09%1.300241.43%1.348433.96%0.95915.37%0.367127.06%1.139611.88%0.953425.60%0.7159
Diluted earning per share 0.83%1.35966.35%1.019910.93%0.40514.09%1.300242.55%1.348433.96%0.95914.74%0.365127.06%1.139611.00%0.945925.60%0.7159
Other composite income -103.06%-2.8K-100.85%-781.09-101.53%-1.32K-41.41%858.64K719.17%91.3K1,698.87%92.05K16,679.61%86.31K120.94%1.47M886.13%11.15K380.46%5.12K
Other composite income of parent company owners -103.06%-2.8K-100.85%-781.09-101.53%-1.32K-53.18%858.44K719.17%91.3K1,698.87%92.05K16,679.61%86.31K128.00%1.83M886.13%11.15K380.46%5.12K
Other composite income of minority owners ------------100.06%205.24------------18.19%-367.98K--------
Total composite income 2.02%1.41B5.63%1.05B5.55%404.71M7.42%1.33B35.43%1.38B29.91%997.36M11.02%383.42M27.97%1.24B10.56%1.02B23.31%767.73M
Total composite income of parent company owners 1.07%1.4B6.27%1.05B10.97%416.11M12.86%1.33B41.24%1.38B33.69%984.78M12.95%374.96M27.20%1.18B10.08%978.69M23.89%736.64M
Total composite income of minority owners 900.82%14.7M-44.33%7M-234.83%-11.4M-113.38%-7.12M-96.59%1.47M-59.54%12.58M-36.85%8.45M47.85%53.22M22.50%43.09M11.03%31.09M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Macrobiotic NMN
Macrobiotic NMN
Intraday-1.69%
State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%
ShangHai Stock Connect
ShangHai Stock Connect
Intraday-1.84%